Archives
-
Dextromethorphan Hydrobromide in Neuroprotection
2026-08-20
Dextromethorphan hydrobromide is an NMDA receptor antagonist for dissecting excitotoxicity, ion-channel signaling, and neuroprotection. This guide adds an assay-design perspective, showing how to distinguish direct channel effects from downstream protection and how to interpret evidence across disease models.
-
Miltefosine Activates Ras/MEK/ERK in Leukopenia
2026-08-19
The reference study identifies Miltefosine as a small-molecule strategy for leukopenia that promotes neutrophil differentiation and restores myelopoiesis after irradiation. Its combination of cell-based assays, a murine model, transcriptomics, network pharmacology, molecular docking, and ERK inhibition supports the Ras/MEK/ERK cascade as a central mechanism, while leaving clinical translation and pathway selectivity for future work.
-
Withania somnifera Digestion: LC–MS/MS Insights
2026-08-19
A 2026 study combined simulated gastrointestinal digestion, LC–MS/MS, molecular networking, and untargeted metabolomics to determine how Withania somnifera leaf and root extracts change before absorption. Withaferin A and withanoside IV were transformation-prone, whereas withanolide A was comparatively stable, highlighting the importance of digestive stability in botanical pharmacokinetic research.
-
ZCL278: Selective Cdc42 Inhibitor Guide
2026-08-18
ZCL278 is a selective Cdc42 inhibitor with a reported Kd of 11.4 μM and activity in cancer, neuronal, and fibroblast models. Its strongest use is mechanistic interrogation of Cdc42-dependent cell motility, neuronal morphology, and GTPase signaling rather than clinical treatment.
-
Salvianolic Acid B, LH2, and Pulmonary Fibrosis
2026-08-18
The reference study identifies Salvianolic acid B, also known as Dan Shen Suan B, as a natural product that reduces pulmonary fibrosis-associated collagen remodeling by lowering LH2/PLOD2 expression. Its experiments connect LH2 suppression with reduced collagen deposition, epithelial–mesenchymal transition, fibroblast activation, and Wnt/β-catenin signaling, providing a mechanistic basis for extracellular matrix-focused research.
-
Verteporfin (CL 318952) for Reliable Cell Assays
2026-08-17
This scenario-driven guide explains how Verteporfin (SKU A8327) can improve the interpretation of viability, proliferation, cytotoxicity, apoptosis, and autophagy experiments. It provides practical controls for light activation, DMSO handling, concentration selection, and vendor evaluation.
-
10 mM dNTP Mixture: Assay-Ready DNA Synthesis
2026-08-17
The 10 mM dNTP mixture is an equimolar DNA synthesis reagent for PCR, qPCR, sequencing, and polymerase-based assays. This guide goes beyond routine reagent selection by showing how controlled nucleotide inputs can strengthen assay interpretation while clarifying their boundaries in lipid nanoparticle research.
-
Polymyxin B Sulfate: Research Workflows
2026-08-16
Build reproducible membrane-disruption, immune-signaling, and Gram-negative infection assays with Polymyxin B sulfate. This guide connects isolate testing and sepsis models with a practical microbiome-aware framework inspired by recent allergic-rhinitis research.
-
Salvianolic acid B: Reliable Fibrosis Assays
2026-08-15
Learn how Salvianolic acid B, SKU N1806, can help laboratories separate cytotoxicity from antifibrotic activity in viability, proliferation, and extracellular matrix assays. This scenario-based guide covers assay compatibility, protocol optimization, interpretation, and practical product-selection criteria.
-
DFO: A Smarter Workflow for Latent Prints
2026-08-14
DFO (9H-1,8-Diazafluoren-9-one) is more than a fluorescent dye for fingerprint detection: it is a substrate-aware analytical tool. This guide explains its chemistry, handling, workflow decisions, and the assay-design lessons that can be drawn from contemporary mechanistic research.
-
Phosphatase Inhibitor Cocktail 2: Assay Workflows
2026-08-14
Preserve labile phosphorylation states from lysis through Western blotting, co-immunoprecipitation, kinase assays, and tissue workflows with a ready-to-dilute broad-spectrum inhibitor mix. A low-temperature, rationally simplified strategy inspired by recent DT-TRAP findings helps reduce sample variability while keeping phosphoprotein experiments practical.
-
Carbapenemase Gene Transfer in CREC, 2022–2024
2026-08-13
Chen et al. provide a multicenter analysis of carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals. The study combines gene localization, antimicrobial susceptibility testing, conjugation, mobile-element profiling, and ERIC-PCR to show that plasmid-associated blaNDM-1 and highly transferable resistance determinants contribute to both horizontal spread and likely clonal dissemination.
-
2-Deoxy-D-glucose: Glycolysis Research Workflows
2026-08-13
Build reproducible cancer, antiviral, and immunometabolism assays with 2-Deoxy-D-glucose, from stock preparation through cytokine and viability readouts. The guide combines practical 2-DG workflows with whole-blood stimulation, model-specific controls, and troubleshooting for separating metabolic regulation from nonspecific toxicity.
-
Verteporfin (CL 318952) Research Workflows
2026-08-12
Verteporfin combines light-gated phototoxicity with light-independent modulation of autophagy, making it useful for matched mechanistic assays rather than single-endpoint screens. This guide translates its product specifications and senescence-screening insights into practical workflows for ocular, cancer, and cell-death research.
-
SB 431542: ALK5 Inhibitor Workflow Guide
2026-08-12
Use SB 431542 to separate TGF-β-driven Smad2 signaling from downstream changes in proliferation, invasion, and epithelial-to-mesenchymal transition. This workflow guide connects pathway validation in endometriosis models with practical assay design for glioma and anti-tumor immunology research.